Satellos Announces Upcoming Presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

BusinesswireFeb 18 08:15 ET

Satellos Bioscience Completes Enrollment of All Dose Cohorts for Phase 1 SAT-3247 Trial

MT NewswiresFeb 10 08:17 ET

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

newsfileDec 20, 2024 17:03 ET

Satellos Bioscience Secures $40 Million Funding Boost

TipRanksDec 20, 2024 09:38 ET

Satellos Announces Closing of US$40M Public Offering

Yahoo FinanceDec 20, 2024 09:18 ET

Satellos Priced US$40 Million Overnight Marketed Public Offering

MT NewswiresDec 17, 2024 09:19 ET